BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8186345)

  • 1. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
    Caprilli R; Andreoli A; Capurso L; Corrao G; D'Albasio G; Gioieni A; Assuero Lanfranchi G; Paladini I; Pallone F; Ponti V
    Aliment Pharmacol Ther; 1994 Feb; 8(1):35-43. PubMed ID: 8186345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del Retto.
    Frieri G; Pimpo MT; Andreoli A; Annese V; Comberlato M; Corrao G; Palumbo G; Sturniolo GC; Tonelli F; Caprilli R
    Aliment Pharmacol Ther; 1999 May; 13(5):577-82. PubMed ID: 10233180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
    Caprilli R; Corrao G; Taddei G; Tonelli F; Torchio P; Viscido A
    Dis Colon Rectum; 1996 Mar; 39(3):335-41. PubMed ID: 8603558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Florent C; Cortot A; Quandale P; Sahmound T; Modigliani R; Sarfaty E; Valleur P; Dupas JL; Daurat M; Faucheron JL; Lerebours E; Michot F; Belaiche J; Jacquet N; Soulé JC; Rothman N; Gendre JP; Malafosse M
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):229-33. PubMed ID: 8724022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.
    Caprilli R; Cottone M; Tonelli F; Sturniolo G; Castiglione F; Annese V; Papi C; Viscido A; Cammà C; Corrao G; Latella G
    Aliment Pharmacol Ther; 2003 Feb; 17(4):517-23. PubMed ID: 12622760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
    Frieri G; Pimpo MT; Palumbo G; Tonelli F; Annese V; Sturniolo GC; Andreoli A; Comberlato M; Corrao G; Caprilli R
    Am J Gastroenterol; 2000 Jun; 95(6):1486-90. PubMed ID: 10894584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.
    Aliment Pharmacol Ther; 1990 Feb; 4(1):55-64. PubMed ID: 2104074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
    Viscido A; Corrao G; Taddei G; Caprilli R
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):274-9. PubMed ID: 10425569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
    Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
    Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group.
    Brignola C; Cottone M; Pera A; Ardizzone S; Scribano ML; De Franchis R; D'Arienzo A; D'Albasio G; Pennestri D
    Gastroenterology; 1995 Feb; 108(2):345-9. PubMed ID: 7835575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease.
    Klein O; Colombel JF; Lescut D; Gambiez L; Desreumaux P; Quandalle P; Cortot A
    Am J Gastroenterol; 1995 Nov; 90(11):1949-52. PubMed ID: 7484997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease.
    Prantera C; Pallone F; Brunetti G; Cottone M; Miglioli M;
    Gastroenterology; 1992 Aug; 103(2):363-8. PubMed ID: 1634054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease.
    Thomson AB; Wright JP; Vatn M; Bailey RJ; Rachmilewitz D; Adler M; Wilson-Lynch KA
    Aliment Pharmacol Ther; 1995 Dec; 9(6):673-83. PubMed ID: 8824656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
    Nakshabendi IM; Duncan A; Russell RI
    Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease.
    McLeod RS; Wolff BG; Steinhart AH; Carryer PW; O'Rourke K; Andrews DF; Blair JE; Cangemi JR; Cohen Z; Cullen JB
    Gastroenterology; 1995 Aug; 109(2):404-13. PubMed ID: 7615189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders].
    Gendre JP; Mary JY; Florent C; Modigliani R; Colombel JF; Soulé JC; Galmiche JP; Lerebours E; Descos L; Viteau JM
    Ann Gastroenterol Hepatol (Paris); 1993 Oct; 29(5):251-6. PubMed ID: 8250520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible?
    Rutgeerts P
    Neth J Med; 1994 Aug; 45(2):60-4. PubMed ID: 7936007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine.
    Ren J; Wu X; Liao N; Wang G; Fan C; Liu S; Ren H; Zhao Y; Li J
    J Int Med Res; 2013 Feb; 41(1):176-87. PubMed ID: 23569144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-Aminosalicylic acid in the prevention of recurrences of Crohn's disease].
    Del Corso L; Moruzzo D; Romanelli AM; Norpoth M; Pentimone F; Bresci G
    Dtsch Med Wochenschr; 1995 Dec; 120(50):1723-7. PubMed ID: 8542807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In favour of prophylactic treatment for post-operative recurrence in Crohn's disease.
    Caprilli R; Taddei G; Viscido A
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):219-25. PubMed ID: 9675663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.